c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
|
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [31] c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
    Bogoyevitch, Marie A.
    Ngoei, Kevin R. W.
    Zhao, Teresa T.
    Yeap, Yvonne Y. C.
    Ng, Dominic C. H.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03): : 463 - 475
  • [32] c-Jun N-terminal kinase is involved in motility of endothelial cell
    Shin, EY
    Kim, SY
    Kim, EG
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) : 276 - 283
  • [33] The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
    Chen, Jing
    Ye, Chao
    Wan, Chao
    Li, Gang
    Peng, Lianci
    Peng, Yuanyi
    Fang, Rendong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [34] c-Jun N-terminal kinase - c-Jun pathway transactivates Bim to promote osteoarthritis
    Ye, Zhiqiang
    Chen, Yuxian
    Zhang, Rongkai
    Dai, Haitao
    Zeng, Chun
    Zeng, Hua
    Feng, Hui
    Du, Gengheng
    Fang, Hang
    Cai, Daozhang
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2014, 92 (02) : 132 - 139
  • [35] c-Jun N-terminal kinase is involved in motility of endothelial cell
    Eun-Young Shin
    Seok-Yong Kim
    Eung-Gook Kim
    Experimental & Molecular Medicine, 2001, 33 : 276 - 283
  • [36] Role of c-Jun N-terminal Kinase in the Regulation of Vascular Tone
    Zhou, Ming-Sheng
    Schulman, Ivonne Hernandez
    Chadipiralla, Kiranmai
    Raij, Leopoldo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 78 - 83
  • [37] Role of c-Jun NH2-terminal kinase-mediated mitogen-activated protein kinase pathway in response to pesticides in Apis cerana cerana
    Niu, Xiao-Jing
    Wang, Li-Jun
    Meng, Hui
    Wang, Hong-Fang
    Xu, Bao-Hua
    Wang, Chen
    INSECT SCIENCE, 2023, 30 (01) : 47 - 64
  • [38] Licochalcone A, a Natural Inhibitor of c-Jun N-Terminal Kinase 1
    Yao, Ke
    Chen, Hanyong
    Lee, Mee-Hyun
    Li, Haitao
    Ma, Weiya
    Peng, Cong
    Song, Nu Ry
    Lee, Ki Won
    Bode, Ann M.
    Dong, Ziming
    Dong, Zigang
    CANCER PREVENTION RESEARCH, 2014, 7 (01) : 139 - 149
  • [39] Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
    Siddiqui, M. Arshad
    Reddy, Panduranga A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3005 - 3012
  • [40] C-Jun N-terminal kinase signalling pathway in response to cisplatin
    Yan, Dong
    An, GuangYu
    Kuo, Macus Tien
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (11) : 2013 - 2019